PMVP · PMV Pharmaceuticals, Inc.
AI read · Good for PMVP
The AI's read
The results could give PMV a path toward a new treatment for patients with a specific ovarian cancer mutation. The response rate across all patient groups was lower than in the ovarian cancer group. PMV still plans to file for approval in Q1 2027, so the results are not an approval.